| Literature DB >> 26209328 |
Arikin Abdeyrim1,2, Yongping Zhang3,4, Nanfang Li5,6, Minghua Zhao7, Yinchun Wang8, Xiaoguang Yao9, Youledusi Keyoumu10, Ting Yin11.
Abstract
BACKGROUND: Even through narrowing of the upper-airway plays an important role in the generation of obstructive sleep apnea (OSA), the peripheral airways is implicated in pre-obese and obese OSA patients, as a result of decreased lung volume and increased lung elastic recoil pressure, which, in turn, may aggravate upper-airway collapsibility.Entities:
Mesh:
Year: 2015 PMID: 26209328 PMCID: PMC4513967 DOI: 10.1186/s12890-015-0063-6
Source DB: PubMed Journal: BMC Pulm Med ISSN: 1471-2466 Impact factor: 3.317
Anthropometric, spirometric, lung volumes and nocturnal PSG data in the OSA group and non-OSA group for men and women
| Variables | Men ( | Women ( | ||||
|---|---|---|---|---|---|---|
| Non-OSA group ( | OSA group ( |
| Non-OSA group ( | OSA group ( |
| |
| Age, years | 44 ± 8 | 45 ± 10 | 0.605 | 47 ± 9 | 50 ± 9 | 0.091 |
| Height, cm | 172 ± 5.5 | 171 ± 6.3 | 0.269 | 158 ± 5.1 | 157 ± 6.0 | 0.266 |
| Weight, kg | 82 ± 10.4 | 90 ± 14.8 | <0.001 | 74 ± 12.3 | 75 ± 13.5 | 0.698 |
| BMI, kg/m2 | 28.0 ± 3.0 | 30.5 ± 4.2 | <0.001 | 29.7 ± 4.9 | 30.7 ± 5.1 | 0.388 |
| FVC, L | 4.19 ± 0.50 | 4.06 ± 0.62 | 0.117 | 3.07 ± 0.49 | 2.83 ± 0.61 | 0.075 |
| FEV1, L | 3.36 ± 0.44 | 3.28 ± 0.53 | 0.188 | 2.47 ± 0.42 | 2.31 ± 0.47 | 0.125 |
| FEV1/FVC, (% pred) | 100 ± 6.0 | 101 ± 6.4 | 0.285 | 101 ± 7.4 | 103 ± 6.9 | 0.231 |
| PEF, L/s | 8.36 ± 1.33 | 8.12 ± 1.60 | 0.266 | 6.02 ± 1.10 | 5.78 ± 0.97 | 0.350 |
| MEF75, L/s | 7.16 ± 1.38 | 6.86 ± 1.40 | 0.132 | 5.39 ± 1.27 | 5.31 ± 1.15 | 0.785 |
| MEF50, L/s | 4.02 ± 0.96 | 3.80 ± 1.13 | 0.158 | 3.29 ± 1.13 | 3.04 ± 0.84 | 0.300 |
| MEF25, L/s | 1.43 ± 0.52 | 1.35 ± 0.56 | 0.138 | 1.12 ± 0.61 | 0.98 ± 0.40 | 0.275 |
| MEF25–75, L/s | 3.30 ± 0.87 | 3.13 ± 0.98 | 0.325 | 2.59 ± 0.97 | 2.40 ± 0.71 | 0.355 |
| ERV, L | 1.56 ± 0.55 | 1.26 ± 0.53 | <0.001 | 1.09 ± 0.53 | 0.83 ± 0.40 | 0.022 |
| FRC, L | 3.73 ± 0.57 | 3.40 ± 0.62 | <0.001 | 2.87 ± 0.57 | 2.60 ± 0.47 | 0.037 |
| TLC, L | 6.24 ± 0.61 | 6.08 ± 0.74 | 0.103 | 4.70 ± 0.48 | 4.50 ± 0.62 | 0.140 |
| RV, L | 2.17 ± 0.38 | 2.15 ± 0.41 | 0.740 | 1.78 ± 0.32 | 1.77 ± 0.32 | 0.953 |
| IC, L | 2.51 ± 0.55 | 2.68 ± 0.56 | 0.041 | 1.83 ± 0.39 | 1.90 ± 0.45 | 0.494 |
| VC, L | 4.07 ± 0.56 | 3.93 ± 0.64 | 0.124 | 2.92 ± 0.45 | 2.73 ± 0.53 | 0.102 |
| ERV/TLC, % | 25.0 ± 8.2 | 20.5 ± 7.8 | <0.001 | 23.0 ± 9.4 | 18.4 ± 8.4 | 0.035 |
| FRC/TLC, % | 59.8 ± 7.5 | 55.9 ± 7.4 | <0.001 | 61.0 ± 8.0 | 57.2 ± 7.8 | 0.046 |
| RV/TLC, % | 34.8 ± 5.6 | 35.5 ± 5.8 | 0.425 | 37.9 ± 6.3 | 39.5 ± 6.6 | 0.275 |
| I C/TLC, % | 40.2 ± 7.5 | 44.0 ± 7.6 | 0.001 | 39.1 ± 7.9 | 42.1 ± 8.0 | 0.121 |
| VC/TLC, % | 65.6 ± 5.6 | 64.6 ± 5.7 | 0.501 | 62.2 ± 6.3 | 60.5 ± 6.6 | 0.274 |
| AI, events/h | 0.2(0–4.4) | 20.0(0–101.7) | <0.001† | 0(0–2.7) | 2.6(0–57.6) | <0.001† |
| HI, events/h | 2.4(0–9.2) | 9.7(0.1–40.9) | <0.001† | 2.7(0–6.5) | 20.0(2.8–86) | <0.001† |
| AHI, events/h | 3.6(0–10) | 30.8(10.4–102.1) | <0.001† | 3.2(0–6.5) | 23.6(5.4–86.2) | <0.001† |
Abbreviations: BMI body mass index, FVC forced vital capacity, FEV forced expiratory volume in 1 s, FEV /FVC(%, pred) ratio of FEV1 to FVC (ratio of the value to the predicted FEV1/FVC), PEF peak expiratory flow, MEF maximal expiratory flow at 75 %, 50 %, and 25 % of FVC, ERV expiratory reserve volume, FRC functional residual capacity, RV residual volume, TLC total lung capacity, IC inspiratory capacity, VC vital capacity, ERV/TLC ratio of ERV to TLC, AI apnea index, HI hypopnea index, AHI apnea + hypopnea index. Normally distributed data are expressed as mean ± SD; AI, HI and AHI are expressed as median (range). Comparison was made between the groups using the Independent-Samples t-test or t’-test, when data for variables showed a normal distribution and homogeneity or inhomogeneity of variances, otherwise, Wilcoxon test was used. A p-value below 0.05 was considered to be significant. † represents Mann–Whitney-Wilcoxon test
Relationship between lung volumes and AHI after adjustment for BMI by multiple regression analysis in males
| Model | Step | Explanatory variable | Standardized coefficients |
|
| Partial correlation | Collinearity statistics | |
|---|---|---|---|---|---|---|---|---|
| Included variables | Beta | Tolerance | VIF | |||||
| 1 | First | (Constant) | −4.830 | <0.001 | ||||
| BMI | 0.441 | 6.782 | <0.001 | 0.441 | 1.000 | 1.000 | ||
| 2 | Second | (Constant) | −3.271 | 0.001 | ||||
| BMI | 0.413 | 6.297 | <0.001 | 0.416 | 0.963 | 1.039 | ||
| ERV | −0.143 | −2.188 | 0.030 | −0.157 | 0.963 | 1.039 | ||
| 3 | (Constant) | −1.943 | 0.054 | |||||
| BMI | 0.408 | 6.156 | <0.001 | 0.408 | 0.943 | 1.060 | ||
| FRC | −0.136 | −2.043 | 0.042 | −0.147 | 0.943 | 1.060 | ||
| Excluded variables | ||||||||
| A | First | age | 0.042 | 0.615 | 0.539 | 0.045 | 0.921 | 1.086 |
| height | 0.026 | 0.402 | 0.688 | 0.029 | 0.998 | 1.002 | ||
| weight | 0.102 | 0.716 | 0.475 | 0.052 | 0.207 | 4.830 | ||
| TLC | −0.077 | −1.183 | 0.283 | −0.086 | 1.000 | 1.000 | ||
| RV | 0.000 | −0.008 | 0.993 | 0.000 | 0.991 | 1.009 | ||
| IC | 0.045 | 0.679 | 0.498 | 0.049 | 0.946 | 1.057 | ||
| VC | −0.085 | −1.318 | 0.189 | −0.095 | 0.999 | 1.001 | ||
Dependent variable: apnea + hypopnea index (AHI). Independent variables: age, height, weight, body mass index (BMI) and total lung capacity (TLC), inspiratory capacity (IC), vital capacity (VC), residual volume (RV), expiratory reserve volume (ERV) or functional residual capacity (FRC). Models 1 and 2 derived from ERV; Models 1 and 3 derived from FRC combined with other independent variables. Variables shown in Model A were excluded variables and were derived from the first of the regression analysis with AHI as dependent and ERV or FRC combined with other independent variables
Comparison of the mechanical properties of respiratory measurement using IOS for men and women
| Parameters | Men ( | Women ( | ||||
|---|---|---|---|---|---|---|
| Non-OSA group ( | OSA group ( |
| Non-OSA group ( | OSA group ( |
| |
| Zrs5, (kPa/L/s) | 0.37 ± 0.11 | 0.45 ± 0.13 | <0.001 | 0.53 ± 0.14 | 0.61 ± 0.18 | 0.033 |
| R5, (kPa/L/s) | 0.35 ± 0.10 | 0.43 ± 0.12 | <0.001 | 0.50 ± 0.13 | 0.57 ± 0.15 | 0.041 |
| R10,(kPa/L/s) | 0.32 ± 0.09 | 0.38 ± 0.09 | <0.001 | 0.44 ± 0.11 | 0.47 ± 0.11 | 0.140 |
| R15,(kPa/L/s) | 0.30 ± 0.07 | 0.34 ± 0.08 | <0.001 | 0.40 ± 0.10 | 0.42 ± 0.09 | 0.242 |
| R20,(kPa/L/s) | 0.30 ± 0.07 | 0.35 ± 0.08 | <0.001 | 0.40 ± 0.09 | 0.42 ± 0.10 | 0.350 |
| R25,(kPa/L/s) | 0.30 ± 0.08 | 0.36 ± 0.09 | <0.001 | 0.41 ± 0.08 | 0.42 ± 0.09 | 0.434 |
| R35,(kPa/L/s) | 0.33 ± 0.07 | 0.39 ± 0.09 | <0.001 | 0.43 ± 0.08 | 0.45 ± 0.09 | 0.317 |
| Grs, (L/s/kPa) | 2.78 ± 0.64 | 2.26 ± 0.50 | <0.001 | 1.92 ± 0.45 | 1.61 ± 0.33 | 0.002 |
| sGrs, (s−1 · kPa−1) | 0.76 ± 0.19 | 0.68 ± 0.17 | 0.007 | 0.68 ± 0.17 | 0.63 ± 0.17 | 0.171 |
| Gz, (L/s/kPa) | 2.94 ± 0.75 | 2.40 ± 0.63 | <0.001 | 2.04 ± 0.55 | 1.76 ± 0.44 | 0.021 |
| sGz, (s−1 · kPa−1) | 0.80 ± 0.22 | 0.72 ± 0.19 | 0.031 | 0.72 ± 0.19 | 0.69 ± 0.21 | 0.363 |
| X5,(kPa/L/s) | −0.08 ± 0.05 | −0.13 ± 0.08 | <0.001 | −0.15 ± 0.07 | −0.22 ± 0.13 | 0.008 |
| X10,(kPa/L/s) | −0.03 ± 0.04 | −0.05 ± 0.06 | <0.001 | −0.07 ± 0.06 | −0.12 ± 0.09 | 0.030 |
| X15,(kPa/L/s) | 0.00 ± 0.04 | −0.02 ± 0.05 | <0.001 | −0.04 ± 0.06 | −0.08 ± 0.08 | 0.033 |
| X20,(kPa/L/s) | 0.03 ± 0.03 | 0.02 ± 0.04 | 0.002 | 0.03 ± 0.18 | −0.03 ± 0.06 | 0.029 |
| X25,(kPa/L/s) | 0.07 ± 0.03 | 0.06 ± 0.04 | 0.060 | 0.05 ± 0.04 | 0.02 ± 0.05 | 0.027 |
| X35,(kPa/L/s) | 0.12 ± 0.04 | 0.11 ± 0.04 | 0.646 | 0.09 ± 0.04 | 0.09 ± 0.04 | 0.911 |
| Fres,(Hz) | 14.4 ± 4.7 | 17.7 ± 6.0 | <0.001 | 19.4 ± 7.4 | 23.5 ± 9.3 | 0.081 |
Abbreviations: Zrs5 respiratory system impedance at 5Hz (oscillatory frequency), R5 ~ R35 respiratory system resistance at 5, 10, 15, 20, 25, 35 oscillatory frequencies, X5 ~ X35 respiratory system reactance at 5, 10, 15, 20, 25, 35Hz, Grs respiratory conductance, reciprocal of R0 (total respiratory resistance, namely the resistance origin at the point of zero frequency), sGrs the specific Grs (the ratio of Grs to actual value of FRC), Gz reciprocal of Zrs5, sGz the specific Gz (the ratio of Gz to actual value of FRC), Fres resonant frequency, integrated area of low-frequency reactance from zero line between X5 and resonant frequency; IOS parameters are expressed as mean ± SD. Comparison was made between the two group using Mann–Whitney-Wilcoxon test. A p-value below 0.05 was considered to exist significant difference
Fig. 1a Respiratory resistance (Rrs) from 5 to 15Hz subjected to linear regression analysis of resistance vs. frequency and resistance at the point of zero-frequency (R0) in males in the non-OSA and OSA groups. b Rrs from 5 to 15Hz subjected to linear regression analysis of resistance vs. frequency and resistance at R0 in females in the non-OSA and OSA groups
Fig. 2a and b Correlation between respiratory system impedance at 5 oscillatory frequency (Zrs5) and back extrapolation of zero-frequency resistance (R0) in males and females (a and b)
Fig. 3a Correlation between severity of obstructive sleep apnea (OSA) as defined by Apnea-Hypopnea Index (AHI) and zero-frequency resistance (R0), Zrs5, R5, and Grs in males. b Correlation between severity of obstructive sleep apnea (OSA) as defined by Apnea-Hypopnea Index(AHI) or Hypopnea Index(HI) and zero-frequency resistance (R0), Zrs5, R5, and Grs in females
Spearman correlation coefficient between respiratory reactance at 5 Hz (Xrs5) and Zrs5, R0, and R5 for male and female subjects
| Parameter | Male (n = 180) |
| Female (n = 70) |
|
|---|---|---|---|---|
| Xrs5 | Xrs5 | |||
| Respiratory impedance at 5 Hz (Zrs5) | −0.638 | <0.001 | −0.725 | <0.001 |
| Respiratory resistance at 0 Hz (R0) | −0.590 | <0.001 | −0.644 | <0.001 |
| Respiratory resistance at 5 Hz (R5) | −0.577 | <0.001 | −0.637 | <0.001 |
Multiple stepwise regression analysis of the association of reactance measured at 5Hz with the severity of OSA
| Model | Unstandardized Coefficients | Standardized Coefficients |
|
| 95 % Confidence Interval for B | Correlation coefficients | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| B | Beta | Lower Bound | Upper Bound | Zero-order | Partial | Part | ||||
| 1 | Constant | 2.623 | 0.916 | 0.361 | −3.028 | 8.274 | ||||
| X5 | −173.294 | −0.504 | −7.784 | <0.001 | −217.288 | −129.361 | −0.504 | −0.504 | −0.504 | |
| 2 | Constant | −40.982 | −4.404 | <0.001 | −59.344 | −22.619 | ||||
| X5 | −144.800 | −0.421 | −6.659 | <0.001 | −187.714 | −101.887 | −0.504 | −0.448 | −0.406 | |
| weight | 0.584 | 0.310 | 4.896 | <0.001 | 0.327 | 0.786 | 0.422 | 0.345 | 0.298 | |
| 3 | Constant | 0.225 | 0.056 | 0.955 | −7.775 | 8.225 | ||||
| X5 | −85.332 | −0.482 | −4.539 | <0.001 | −122.847 | −47.819 | −0.482 | −0.482 | −0.482 | |
| 4 | Constant | −25.415 | −2.061 | 0.043 | −50.035 | 0.796 | ||||
| X5 | −74.946 | −0.424 | −3.966 | <0.001 | −112.688 | −37.223 | −0.482 | −0.436 | −0.410 | |
| BMI | 0.912 | 0.234 | 2.191 | 0.032 | 0.081 | 1.744 | 0.340 | 0.259 | 0.227 | |
| 5 | Constant | −3.143 | −1.046 | 0.299 | −9.141 | 2.855 | ||||
| X5 | −84.601 | −0.589 | −6.002 | <0.001 | −112.726 | −56.476 | −0.589 | −0.589 | −0.589 | |
| 6 | Constant | −23.130 | −2.059 | 0.015 | −41.536 | −4.726 | ||||
| X5 | −76.504 | −0.532 | −5.415 | <0.001 | −104.704 | −48.305 | −0.589 | −0.552 | −0.515 | |
| BMI | 0.711 | 0.225 | 2.258 | 0.025 | 0.090 | 1.333 | 0.358 | 0.269 | 0.217 | |
Independent variables: Zrs5, Gz, sGz, Grs, sGrs, R5, X5, X10, X15; Dependent Variable: AHI or HI. Model 1, 2 derived from male subject data by performing stepwise regression analysis; model 3, 4 derived from female subject data; model 5, 6 derived from female subject data with HI as a dependent variable
Abbreviations: BMI body mass index, X5 respiratory system reactance at 5Hz, AHI apnea + hypopnea index, HI hypopnea index, Zrs5 respiratory system impedance at 5Hz (oscillatory frequency), R5 respiratory system resistance at 5 oscillatory frequencies, Grs respiratory conductance, reciprocal of R0 (total respiratory resistance, namely the resistance origin at the point of zero frequency), sGrs the specific Grs (the ratio of Grs to actual value of FRC), Gz reciprocal of Zrs5, sGz the specific Gz (the ratio of Gz to actual value of FRC)
Correlation between FRC and reactance at all frequencies derived from stepwise regression analysis in males and females
| Model | Explanatory variable | Standardized coefficients |
|
| Partial correlation | Co-linearity statistics | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Included variables | Beta Male | Beta Female | Male | Female | Male | Female | Male | Female | Tolerance Male | Tolerance Female | |
| 1 | (Constant) | 46.575 | 25.286 | <0.001 | <0.001 | ||||||
| X5 | 0.320 | 0.326 | 4.501 | 2.842 | <0.001 | 0.006 | 0.320 | 0.326 | 1.000 | 1.000 | |
| Excluded variables | |||||||||||
| A | X10 | 0.106 | 0.090 | 0.907 | 0.343 | 0.366 | 0.732 | 0.068 | 0.042 | 0.366 | 0.193 |
| X15 | 0.107 | 0.081 | 1.091 | 0.394 | 0.277 | 0.695 | 0.082 | 0.048 | 0.523 | 0.314 | |
| X20 | 0.160 | 0.001 | 1.846 | 0.010 | 0.067 | 0.992 | 0.137 | 0.001 | 0.663 | 0.870 | |
| X25 | 0.023 | −0.089 | 0.290 | −0.596 | 0.772 | 0.553 | 0.022 | −0.073 | 0.784 | 0.597 | |
| X35 | 0.005 | −0.061 | 0.070 | −0.478 | 0.945 | 0.634 | 0.005 | −0.058 | 0.865 | 0.817 | |
| AHI | −0.133 | −0.121 | −1.745 | −1.025 | 0.083 | 0.309 | −0.130 | −0.124 | 0.853 | 0.937 | |
| BMI | −0.111 | −0.103 | −1.351 | −0.784 | 0.178 | 0.436 | −0.101 | −0.095 | 0.747 | 0.767 | |
Dependent variable: functional residual capacity (FRC). Independent variables: respiratory reactance at 5, 10, 15, 20, 25, 35 Hz (X5 ~ X35), apnea + hypopnea index (AHI) and body mass index (BMI). Variables showed in Model A were excluded variables and was derived from the regression analysis
Fig. 4Respiratory reactance at different oscillatory frequency measured by IOS for males and females subjects in the non-OSA and OSA groups. Solid line between the reactance at various oscillatory frequency represent linear interrelationship were plotted using the least squares method